Afterward: The Future of Patient-Derived Models of Cancer

@inproceedings{Hoffman2017AfterwardTF,
  title={Afterward: The Future of Patient-Derived Models of Cancer},
  author={Robert M. Hoffman},
  year={2017}
}
Patient-tumor mouse models were first developed in 1969. There was a great flurry of research on these models in the 1970s and 1980s, including drug-response testing for patient-tumor donors. Patient-derived mouse models have had a great resurgence since the early part of the present century. However, there is still only very scattered use of the patient mouse models for directing patient therapy. The future holds promise for the use of patient mouse models, especially those that metastasize… CONTINUE READING

Topics from this paper.

Similar Papers

Loading similar papers…